Description
ARA-290 (cibinetide) is a non-erythropoietic peptide engineered from the tissue-protective domain of erythropoietin. It selectively activates the innate repair receptor to promote anti-inflammatory effects, cytoprotection, and nerve regeneration without increasing red blood cell production. Research shows potential benefits for neuropathic pain, small fiber neuropathy, diabetes-related complications, and tissue repair in conditions like sarcoidosis. It is studied primarily as an injectable peptide for neuroprotection and healing.
Reviews
There are no reviews yet.